Scott Halperin, MD
Dr. Halperin earned his undergraduate degree at Stanford University and his medical degree from Cornell University. He completed his pediatric residency at the University of Virginia, Charlottesville, followed by training in pediatric allergy and infectious disease at the University of Virginia and in pediatric infectious disease at the University of Minnesota, Minneapolis. He came to Dalhousie University in 1985, where he is Professor of
Pediatrics and Associate Professor of Microbiology & Immunology. He is also Head of Infectious Diseases at the IWK Grace Health Center and Director of the Clinical Trials Research Center.
Dr. Halperin's laboratory research originally focused on pertussis and protective antigens of Bordetella pertussis; his clinical and epidemiological research related to the diagnosis and treatment of pertussis. In 1991, he broadened his research to include clinical trials
involving vaccines (pertussis and others).
In 1992, Dr. Halperin established the Clinical Trials Research Center, which has grown to over 30 staff involved in the design, performance, management, analysis, and reporting of clinical trials related to infections in children.
Dr. Halperin established collaboration with Dr. Song Lee through DIDRA, and they are currently using the animal model of pertussis to explore the feasibility of an oral vaccine against pertussis. This vaccine uses Streptococcus gordonii expressing genes for pertussis protective antigens.
Research Services Available
Dr. Halperin directs the Clinical Trials Research Center (CTRC), which offers research services particularly in the field of infectious diseases, including epidemiological research and clinical trials with drugs and biologics. All aspects of study design, implementation, management, and analysis are offered.